Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
Genetic Testing and Molecular Biomarkers|May 2, 2009
Identification of patients at high risk of psychological distress after BRCA1 genetic testingSławomir Ertmański, Kelly Metcalfe, Janusz Trempała, et al.
Breast Cancer Research and Treatment|November 2, 2005
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from PolandJacek Gronwald, Tomasz Byrski, Tomasz Huzarski, et al.
Hereditary Cancer in Clinical Practice|March 2, 2018
Frequency of <i>BRCA1</i> and <i>BRCA2</i> causative founder variants in ovarian cancer patients in South-East PolandTomasz Kluz, Andrzej Jasiewicz, Elżbieta Marczyk, et al.
Hereditary Cancer in Clinical Practice|June 13, 2023
Genetic testing for hereditary breast cancer in Poland: 1998-2022Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, et al.
BMC Cancer|November 14, 2025
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancerPeteris Loza, Arvids Irmejs, Zanda Daneberga, et al.
International Journal of Molecular Sciences|June 26, 2026
The Potential Role of Vitamin D in <i>BRCA1</i> Pathogenic Variant Carriers: A Narrative ReviewJoanna Robaczyńska, Milena Kiljańczyk, Maciej Maj, et al.
Hereditary Cancer in Clinical Practice|June 5, 2026
Are current Polish guidelines for prophylactic mastectomy sufficient?Adam Stachowski, Cezary Cybulski, Jacek Gronwald, et al.
Ginekologia Polska|November 7, 2013
[Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries]Janusz Menkiszak, Anita Chudecka-Głaz, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|April 2, 2005
Pathology of breast cancer in women with constitutional CHEK2 mutationsTomasz Huzarski, Cezary Cybulski, Wenancjusz Domagała, et al.
Breast Cancer Research and Treatment|September 28, 2006
The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutationAnna Jakubowska, Jacek Gronwald, Bohdan Górski, et al.
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
Genetic Testing and Molecular Biomarkers|May 2, 2009
Identification of patients at high risk of psychological distress after BRCA1 genetic testingSławomir Ertmański, Kelly Metcalfe, Janusz Trempała, et al.
Breast Cancer Research and Treatment|November 2, 2005
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from PolandJacek Gronwald, Tomasz Byrski, Tomasz Huzarski, et al.
Hereditary Cancer in Clinical Practice|March 2, 2018
Frequency of <i>BRCA1</i> and <i>BRCA2</i> causative founder variants in ovarian cancer patients in South-East PolandTomasz Kluz, Andrzej Jasiewicz, Elżbieta Marczyk, et al.
Hereditary Cancer in Clinical Practice|June 13, 2023
Genetic testing for hereditary breast cancer in Poland: 1998-2022Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, et al.
BMC Cancer|November 14, 2025
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancerPeteris Loza, Arvids Irmejs, Zanda Daneberga, et al.
International Journal of Molecular Sciences|June 26, 2026
The Potential Role of Vitamin D in <i>BRCA1</i> Pathogenic Variant Carriers: A Narrative ReviewJoanna Robaczyńska, Milena Kiljańczyk, Maciej Maj, et al.
Hereditary Cancer in Clinical Practice|June 5, 2026
Are current Polish guidelines for prophylactic mastectomy sufficient?Adam Stachowski, Cezary Cybulski, Jacek Gronwald, et al.
Ginekologia Polska|November 7, 2013
[Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries]Janusz Menkiszak, Anita Chudecka-Głaz, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|April 2, 2005
Pathology of breast cancer in women with constitutional CHEK2 mutationsTomasz Huzarski, Cezary Cybulski, Wenancjusz Domagała, et al.
Breast Cancer Research and Treatment|September 28, 2006
The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutationAnna Jakubowska, Jacek Gronwald, Bohdan Górski, et al.
Pageof 31